Eva Petermann

8.3k citations
50 papers · 6.7k · 3 hit papers · h-index 34

Impact in

    • DNA Repair Mechanisms
    • Genomics and Chromatin Dynamics
    • DNA and Nucleic Acid Chemistry
    • Cancer therapeutics and mechanisms
  • Oncology top 2%
    • PARP inhibition in cancer therapy
    • Cancer-related Molecular Pathways

Papers in

    • DNA Repair Mechanisms 41
    • Protein Degradation and Inhibitors 3
    • Genomics and Chromatin Dynamics 2
    • Chromatin Remodeling and Cancer 2
    • Cancer-related Molecular Pathways 3
    • PARP inhibition in cancer therapy 2

Eva Petermann

50 papers receiving 6.6k citations

Eva Petermann's Hit Papers

Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids 2022 · 265 citations
2650+6+12Years since publication4008001.2k

Peers

Eva Petermann
Comparison fields: 5 of 98
  • Molecular Biology 4.7k
  • Oncology 1.5k
  • Cancer Research 386
  • Genetics 165
  • Cell Biology 154
Replace Christine E. Canman with:
Christine E. Canman United States
Mu‐Shui Dai United States
Hariharan Easwaran United States
Nicole L. Solimini United States
Jacob Falck Denmark
Randi G. Syljuåsen Norway
Jonathan D. Oliner United States
Kristen E. Hurov United States
Gabriella Zupi Italy
Andrew James Pierce United States
Eva Petermann relative to Christine E. Canman United States Christine E. Canman's profile →
Citations per field
00.5×2×4×5.3×
Christine E. Canman · 1×
Citations per year

Countries citing papers authored by Eva Petermann

Since Specialization
Citations

This map shows the geographic impact of Eva Petermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Petermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Petermann more than expected).

Fields of papers citing papers by Eva Petermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Petermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Petermann. The network helps show where Eva Petermann may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Petermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Petermann Line = papers co-authored together Eva Petermann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#Work
1
DNA repair pathways as targets for cancer therapy
Hit paper breakdown →
20081417
2
Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair
Hit paper breakdown →
2010673
3 2009510
4 2018304
5 2006295
6 2010282
7 2016267
8
Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids
Hit paper breakdown →
2022265
9 2015243
10 2010233
11 2012230
12 2007197
13 2018189
14 2006153
15 2006114
16 2008105
17 2012100
18 200897
19 202092
20 201377

About Eva Petermann

Eva Petermann is a scholar working on Molecular Biology, Oncology, Genetics, Biotechnology and Public Health, Environmental and Occupational Health, having authored 50 papers that have together received 6.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (41 papers), Chronic Lymphocytic Leukemia Research (3 papers), Protein Degradation and Inhibitors (3 papers), Cancer-related Molecular Pathways (3 papers), Genomics and Chromatin Dynamics (2 papers), PARP inhibition in cancer therapy (2 papers), Chromatin Remodeling and Cancer (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Molecular Biology (4.7k citations), Oncology (1.5k citations), Cancer Research (386 citations), Genetics (165 citations) and Cell Biology (154 citations). Eva Petermann has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Thomas Helleday, Ben Hodgson, Ricky A. Sharma, Cecilia Lundin, Niklas Schultz, Natalia Issaeva, Keith W. Caldecott, Panagiotis Kotsantis, Rebecca M. Jones and Manuel Luís Orta. Their work appears in journals such as Nature Communications, Blood, The EMBO Journal, Molecular Cancer Therapeutics and DNA repair.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact